Compare NKTX & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | LOVE |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 227.3M |
| IPO Year | 2020 | 2018 |
| Metric | NKTX | LOVE |
|---|---|---|
| Price | $2.93 | $17.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $11.33 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 794.4K | 242.4K |
| Earning Date | 05-11-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $697,115,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | N/A | $6.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.42 |
| 52 Week Low | $1.70 | $10.33 |
| 52 Week High | $3.72 | $20.88 |
| Indicator | NKTX | LOVE |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 54.31 |
| Support Level | $2.50 | $13.55 |
| Resistance Level | $3.29 | $17.69 |
| Average True Range (ATR) | 0.31 | 1.07 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 22.91 | 58.96 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.